abstract |
The present invention relates to fused bicyclic metalloproteinase inhibitors of the formula (I) wherein ring B is selected from the group consisting of: (II), (III), (IV), (V) and A, X, Y, and R1 are as defined in the specification, and to pharmaceutical compositions and methods of treating arthritis, inflammation, cancer and other disorders. |